ANDER
URRUTICOECHEA RIBATE
Centro Nacional de Investigaciones Oncológicas
Madrid, EspañaPublications in collaboration with researchers from Centro Nacional de Investigaciones Oncológicas (5)
2017
-
Resistance to Taxanes in Triple-Negative Breast Cancer Associates with the Dynamics of a CD49f+ Tumor-Initiating Population
Stem Cell Reports, Vol. 8, Núm. 5, pp. 1392-1407
2014
-
Phase I clinical trial of nintedanib plus paclitaxel in early HER-2-negative breast cancer (CNIO-BR-01-2010/GEICAM-2010-10 study).
British journal of cancer, Vol. 111, Núm. 6, pp. 1060-1064
2011
-
Evidence for a link between TNFRSF11A and risk of breast cancer
Breast Cancer Research and Treatment, Vol. 129, Núm. 3, pp. 947-954
-
Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer
PLoS Biology, Vol. 9, Núm. 11
2010
-
Biological reprogramming in acquired resistance to endocrine therapy of breast cancer
Oncogene, Vol. 29, Núm. 45, pp. 6071-6083